Skip to main content

Table 1 Clinical data of CAH patients

From: Novel deletion alleles carrying CYP21A1P/A2chimeric genes in Brazilian patients with 21-hydroxylase deficiency

Case

Sex1

Age at diagnosis2

Clinical Data

basal 17OHP (nmol/L)

Na+/K+(mmol/L)

Phenotype3

1

M

1 m 28 d

vomiting, dehydration

na4

129/6.2

SW

2

F

12 d

ambiguous genitalia; Prader III

> 20 ndm5

137/6.2

SW

3

M

2 m 24 d

vomiting, dehydration

49.3

116/9.2

SW

4

F

19 d

vomiting, dehydration; registered as male

na

128/7.8

SW

5

M

31 d

vomiting, dehydration

> 20 ndm

120/5.5

SW

6

M

2 m 8 d

vomiting, dehydration

> 200 ndm

121/6.8

SW

7

F

10 m

ambiguous genitalia; Prader III

> 25 ndm

142/5.0

SV

8

F

6 d

ambiguous genitalia; Prader III/IV

> 200 ndm

123/7.4

SW

9

F

np

ambiguous genitalia; Prader IV

  

SW

10

M

1 yr 1 m

vomiting, dehydration

> 25 ndm

120/6.8

SW

11

F

6 yr 3 m

precocious pubarche since 4 yr 6 m; high stature

> 25 ndm

nt

NC

12

F

10 d

ambiguous genitalia; Prader III

> 20 ndm

121/6.5

SW

13

F

np

ambiguous genitalia; Prader III/IV; vomiting, dehydration; registered as male

na

na

SW

14

F

np

ambiguous genitalia; Prader III

na

na

SW

15

F

14 d

ambiguous genitalia; Prader IV

> 6 ndm

119/5.3

SW

16

M

28 d

vomiting, dehydration, adrenal crysis

> 200 ndm

119/9.7

SW

17

M

3 yr 5 m

precocious pubarche since 2 yr

> 20 ndm

na

SV

18

M

6 yr

precocious pubarche

> 20 ndm

na

SV

19

F

5 yr 7 m

precocious pubarche, ambiguous genitalia; Prader IV

238

na

SV

20

F

37 d

ambiguous genitalia; Prader III

> 20 ndm

136/5.7

SV

  1. 1F = Female, M = male; 2yr = years, m = months, d = days, np = neonatal period; 3SW = salt-wasting, SV = simple virilizing, NC = non-classic; 4na = not available; 5ndm = non-diluted measurements (ref value 5.97 nmol/L).